Blood News and Research

RSS

Tafinlar, Mekinist get FDA approval to treat patients with advanced melanoma

The U.S. Food and Drug Administration today approved two new drugs, Tafinlar (dabrafenib) and Mekinist (trametinib), for patients with advanced (metastatic) or unresectable (cannot be removed by surgery) melanoma, the most dangerous type of skin cancer.

30 May 2013

Coronavirus incubation period may be longer than previously thought

A detailed clinical description of two cases of Middle East Respiratory Syndrome coronavirus (MERS-CoV) in France, published online in The Lancet today, suggests that the incubation period for the virus may be longer than previously thought, and longer quarantine periods may be required to rule out infection among patient contacts.

29 May 2013

Adult stem cells combined with new drug could hold key to curing type 1 diabetes

Millions of people with type 1 diabetes depend on daily insulin injections to survive. They would die without the shots because their immune system attacks the very insulin-producing cells it was designed to protect. Now, a University of Missouri scientist has discovered that this attack causes more damage than scientists realized. The revelation is leading to a potential cure that combines adult stem cells with a promising new drug.

29 May 2013

Survival rates increased among patients who received blood stem cell transplants: Study

Survival rates have increased significantly among patients who received blood stem cell transplants from both related and unrelated donors, according to a study published in the Journal of Clinical Oncology today.

29 May 2013

Spherical nanoparticles transform into netlike structures at site of cancer

Scientists at the University of California, San Diego, have designed tiny spherical particles to float easily through the bloodstream after injection, then assemble into a durable scaffold within diseased tissue. An enzyme produced by a specific type of tumor can trigger the transformation of the spheres into netlike structures that accumulate at the site of a cancer, the team reports in the journal Advanced Materials this week.

29 May 2013

FDA approves iTrace for Blood Centers to assist in enhancing blood safety

iTrace for Blood Centers, (Version 1.0.924.0), the first application to use Radio Frequency Identification technology in blood establishments to assist in enhancing blood safety by preventing the release of unsuitable blood components, was cleared today by the U.S. Food and Drug Administration.

29 May 2013

New test to predict increased risk of death, hospitalization among kidney dialysis patients

Johns Hopkins scientists report that a 10-minute test for "frailty" first designed to predict whether the elderly can withstand surgery and other physical stress could be useful in assessing the increased risk of death and frequent hospitalization among kidney dialysis patients of any age.

29 May 2013

Medical researchers identify genetic marker associated with sporadic breast cancer

Medical researchers at the University of Alberta have pinpointed a genetic marker for sporadic breast cancer - one of a handful identified to date in Caucasians.

29 May 2013

Four studies show that OrSense's non-invasive NBM-200 Hb monitor is safe and accurate

OrSense Ltd., developer of monitors for non-invasive measurements of various blood parameters, announced today that its non-invasive Hemoglobin NBM-200 monitor was the topic of multiple recent studies highlighting the clinical value of the device.

28 May 2013

The Global Virus Network to hold spring 2013 meeting in Munich, Germany

The Global Virus Network, a coalition of the world's leading medical virology research centers working to prevent illness and death from viral disease, will hold its spring 2013 meeting in Munich, Germany May 30 to June 1.

28 May 2013

New Smartphone app helps maintain accurate records to manage diabetes

Vital improvements can be made to patients diabetes control, by ensuring a recent blood glucose history is available to their Specialist Nurse. Traditionally patients have recorded their results in a paper logbook but now the new app from GlucoMen is a fantastic alternative using Smartphone technology to ensure a complete and accurate record.

28 May 2013

Findings support ongoing development, implementation of organized stroke care delivery

An integrated system of stroke care delivery in Ontario, Canada, has resulted in fewer deaths from stroke and fewer discharges to long-term care facilities because of better access to optimal stroke care, according to a study published in CMAJ (Canadian Medical Association Journal).

28 May 2013

Lab-based skin test eliminates risk of adverse reactions to new drugs, cosmetics

A simple lab-based skin test which eliminates the risk of adverse reactions to new drugs, cosmetics and household chemicals has been developed by a Newcastle University, UK team.

28 May 2013

Synthetic compound derived from sea anemone toxin shows potential to treat obesity

Scientists at UC Irvine reported this week that a synthetic compound ShK-186, originally derived from a sea anemone toxin, has been found to enhance metabolic activity and shows potential as a treatment for obesity and insulin resistance.

28 May 2013

Omthera to be acquired by AstraZeneca

AstraZeneca today announced that it has entered into a definitive agreement to acquire Omthera Pharmaceuticals, a specialty pharmaceutical company based in Princeton, New Jersey, focused on the development and commercialization of new therapies for abnormal levels of lipids in the blood, referred to as dyslipidemia.

28 May 2013

New deal to bring Mendor's all-in-one blood glucose monitoring system to nine European markets

Mendor, the Finnish diabetes technology company, is proud to announce its partnership with A. Menarini Diagnostics S.r.l, one of Europe's leading diagnostics companies in the field of diabetes.

28 May 2013

New AAN guideline provides direction for use of blood thinners during surgery

A new guideline from the American Academy of Neurology will help people who take blood thinners decide whether or not to take them during surgery or other medical procedures.

28 May 2013

TF-CBT and EMDR are effective treatments for posttraumatic stress disorder

Trauma-focused cognitive-behavioral therapy (TF-CBT) and eye movement desensitization and reprocessing (EMDR) are effective treatments for posttraumatic stress disorder.

27 May 2013

New app for iPhone helps detect toxins, proteins, bacteria and viruses

Researchers and physicians in the field could soon run on-the-spot tests for environmental toxins, medical diagnostics, food safety and more with their smartphones.

27 May 2013

Viewpoints: We need more 'socialism'; The IRS's 'unwelcome role'; 'Fog of Obamacare'

So this is what socialism looks like: Private companies competing for people's business in an open marketplace. Californians got their first glimpse Thursday of what insurers plan to charge for coverage to be offered next year to about 5 million state residents who don't receive health insurance from employers (David Lazarus, 5/23).

27 May 2013

Blood News and Research

Tafinlar, Mekinist get FDA approval to treat patients with advanced melanoma

Coronavirus incubation period may be longer than previously thought

Adult stem cells combined with new drug could hold key to curing type 1 diabetes

Survival rates increased among patients who received blood stem cell transplants: Study

Spherical nanoparticles transform into netlike structures at site of cancer

FDA approves iTrace for Blood Centers to assist in enhancing blood safety

New test to predict increased risk of death, hospitalization among kidney dialysis patients

Medical researchers identify genetic marker associated with sporadic breast cancer

Four studies show that OrSense's non-invasive NBM-200 Hb monitor is safe and accurate

The Global Virus Network to hold spring 2013 meeting in Munich, Germany

New Smartphone app helps maintain accurate records to manage diabetes

Findings support ongoing development, implementation of organized stroke care delivery

Lab-based skin test eliminates risk of adverse reactions to new drugs, cosmetics

Synthetic compound derived from sea anemone toxin shows potential to treat obesity

Omthera to be acquired by AstraZeneca

New deal to bring Mendor's all-in-one blood glucose monitoring system to nine European markets

New AAN guideline provides direction for use of blood thinners during surgery

TF-CBT and EMDR are effective treatments for posttraumatic stress disorder

New app for iPhone helps detect toxins, proteins, bacteria and viruses

Viewpoints: We need more 'socialism'; The IRS's 'unwelcome role'; 'Fog of Obamacare'

A New Approach to Preventing Bladder Cancer Recurrence

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Latest News